{"title":"Phytonanoparticles for food safety and preservation: potential role, evidence and challenges in antimicrobial resistance mitigation.","authors":"Mohsin Ahmed, Bishwambhar Mishra, Sujogya Kumar Panda, Saravanan Muthupandian, Yugal Kishore Mohanta","doi":"10.3389/frabi.2026.1901804","DOIUrl":"10.3389/frabi.2026.1901804","url":null,"abstract":"<p><p>Antimicrobial resistance (AMR) is a global threat to humankind, affecting food safety, health, and the economy. Moreover, it is evolving rapidly, resulting from the misuse and overuse of antibiotics in healthcare and agriculture a result which has emerged as a One Health challenge. It alters food systems by creating threats to food safety, food security, and public health. Such resistant microorganisms have the ability to persist and spread in the food systems, animals, water, and the environment. Such microorganisms are further sustained by the production of biofilms. There is increased demand for safe and sustainable alternatives as a result of the limited applicability of conventional antibiotics and chemical preservatives. Plant-mediated phyto-nanoparticles (PNPs) are emerging antimicrobials. A PRISMA-compliant literature search and bibliometric analysis were used to identify leading research trends and gaps. This review evaluates their applicability in different aspects of food safety and preservation and in mitigating AMR. It includes major foodborne pathogens, resistance mechanisms, biofilm formation, and synthesis of bioactive nanoparticles using plants. The main antimicrobial mechanisms of these nanoparticles include the generation of reactive oxygen species (ROS), disruption of the cell membrane, release of metal ions, enzyme inhibition, DNA damage, and interference with quorum sensing. This review includes their applicability in active food packaging, edible coatings, food preservation, and food processing surfaces. This review expands existing research by including the results of real food matrices and storage studies. The review incorporates the emerging applications of artificial intelligence (AI) and machine learning (ML) in nanoparticles design, prediction of antimicrobial activities, and optimization of synthesis parameters, and trend identification. In general, PNPs have a lot of potential for sustainable approaches to food preservation. However, standardized methods, rigorous safety evaluation, AI/ML-assisted optimization, and real-food, <i>in vivo</i>, and industrial studies are needed for successful translation.</p>","PeriodicalId":73065,"journal":{"name":"Frontiers in antibiotics","volume":"5 ","pages":"1901804"},"PeriodicalIF":3.9,"publicationDate":"2026-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13746010/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149382102","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Frontiers in antibioticsPub Date : 2026-10-12eCollection Date: 2026-01-01DOI: 10.3389/frabi.2026.1954916
Abdulrasheed Ibrahim
{"title":"Whether, or under what conditions? A configurational approach to AI-supported antimicrobial stewardship in sub-Saharan Africa.","authors":"Abdulrasheed Ibrahim","doi":"10.3389/frabi.2026.1954916","DOIUrl":"10.3389/frabi.2026.1954916","url":null,"abstract":"","PeriodicalId":73065,"journal":{"name":"Frontiers in antibiotics","volume":"5 ","pages":"1954916"},"PeriodicalIF":3.9,"publicationDate":"2026-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13698037/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149277977","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Frontiers in antibioticsPub Date : 2026-10-12eCollection Date: 2026-01-01DOI: 10.3389/frabi.2026.1968363
Samar Rashid Abdullahi, Nathan Mugenyi, Lucy Ochola, Jamal Abade Mohamed, Hussein Iman Sigat, Abdirizak Ali Yusuf, Wigilya P Mikomangwa, Armstrong Ndihokubwayo, David Majuch Kunjok, Schifra Uwamungu, Nathan Banzi, Barbra Tuhamize
{"title":"Ceftriaxone-by-default in surgical prophylaxis across the East African community: a measurement problem.","authors":"Samar Rashid Abdullahi, Nathan Mugenyi, Lucy Ochola, Jamal Abade Mohamed, Hussein Iman Sigat, Abdirizak Ali Yusuf, Wigilya P Mikomangwa, Armstrong Ndihokubwayo, David Majuch Kunjok, Schifra Uwamungu, Nathan Banzi, Barbra Tuhamize","doi":"10.3389/frabi.2026.1968363","DOIUrl":"10.3389/frabi.2026.1968363","url":null,"abstract":"<p><p>Surgical antibiotic prophylaxis across the East African Community is dominated by ceftriaxone, a WHO Access, Watch, and Reserve (AWaRe) Watch-group third-generation cephalosporin not recommended for routine prophylaxis. The practice recurs across regional point prevalence surveys, yet consumption surveillance cannot distinguish prophylactic from therapeutic use. Drawing on antimicrobial-use surveys, surgical-prophylaxis studies, resistance surveillance, and medicine-availability reports, we argue that four interacting failure modes sustain it: substitution of first-line agents, prolongation of postoperative prophylaxis, unnecessary combination, and empirical spillover from ward prescribing. Resistance among surgical-site isolates is already high enough to threaten the value of prophylaxis itself. Prophylaxis is measured for duration, documented indication, and guideline concordance, and agent choice is captured in point-prevalence surveys, but none of this reaches the national consumption totals that govern procurement, and no indicator records the supply constraint determining the agent or the resistance it selects. We propose four measures, one requiring routing rather than building and three genuinely absent, that would convert an ungoverned practice into a governable one.</p>","PeriodicalId":73065,"journal":{"name":"Frontiers in antibiotics","volume":"5 ","pages":"1968363"},"PeriodicalIF":3.9,"publicationDate":"2026-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13697196/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149277985","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Frontiers in antibioticsPub Date : 2026-10-09eCollection Date: 2026-01-01DOI: 10.3389/frabi.2026.1933211
Joseph Yamweka Chizimu, Harvey Kakoma Kamboyi, Maisa Kasanga, Taona Sinyawa, Misheck Shawa, Ruth Nakazwe, Steward Mudenda, Joseph Njung'e, Susan Kiiru, Mungunsar Chuluun, Chileshe Lukwesa, Zoran Muhimba, Victor Daka, Dianah Tibatemwa, Everlyn Wesangula, O-Tipo Shikanga, Sandra Diana Mwadetsa, Nchimunya Machila, Veronica Chuchu, Zachariah Mupila, Peter Clement Lasuba, Yasuhiko Suzuki, Flavien Nsoni Bumbangi, Roma Chilengi
{"title":"Genomic insights into multidrug and extensively drug-resistant <i>Klebsiella pneumoniae</i> from bloodstream infections at three Zambian tertiary hospitals.","authors":"Joseph Yamweka Chizimu, Harvey Kakoma Kamboyi, Maisa Kasanga, Taona Sinyawa, Misheck Shawa, Ruth Nakazwe, Steward Mudenda, Joseph Njung'e, Susan Kiiru, Mungunsar Chuluun, Chileshe Lukwesa, Zoran Muhimba, Victor Daka, Dianah Tibatemwa, Everlyn Wesangula, O-Tipo Shikanga, Sandra Diana Mwadetsa, Nchimunya Machila, Veronica Chuchu, Zachariah Mupila, Peter Clement Lasuba, Yasuhiko Suzuki, Flavien Nsoni Bumbangi, Roma Chilengi","doi":"10.3389/frabi.2026.1933211","DOIUrl":"10.3389/frabi.2026.1933211","url":null,"abstract":"<p><strong>Background: </strong><i>Klebsiella pneumoniae</i> is a leading cause of hospital-associated infections and a major contributor to antimicrobial resistance (AMR) worldwide. Despite its importance and prioritisation in Zambia's National Action Plan on AMR, genomic surveillance information in sub-Saharan Africa remains limited. This study investigated the population structure, determinants of AMR, and plasmid diversity of <i>K. pneumoniae</i> isolates from three tertiary hospitals in Zambia.</p><p><strong>Methods: </strong>Thirty archived <i>K. pneumoniae</i> blood isolates collected between December 2023 and May 2025 from University Teaching Hospitals (UTH), Ndola University Teaching Hospital (NUTH), and Livingstone University Teaching Hospital (LUTH) and subjected to antimicrobial susceptibility testing (AST) and whole-genome sequencing (Illumina NextSeq 2000). Sequence types (STs), plasmid replicons, and antimicrobial resistance genes (ARGs) were identified using MLST, PlasmidFinder, and the Comprehensive Antibiotic Resistance Database, respectively.</p><p><strong>Results: </strong>Twenty-eight isolates (93%) were multidrug-resistant, of which seven (25%) were extensively drug-resistant (XDR), exhibiting resistance across eight antibiotic classes, including carbapenems. Whole-genome sequencing identified 18 sequence types (STs), including two novel STs, and globally disseminated high-risk clones such as ST11, ST15, ST101, ST307, ST377, and ST607, which are circulating across hospitals. UTH exhibited the highest diversity of STs. The seven XDR <i>K. pneumoniae</i> isolates, six (85%) were from UTH, while the remaining isolate was from NUTH. Among the XDR isolates, five belonged to clinically dominant clones, comprising ST377 (two isolates) and single representatives of ST101, ST307, and ST607. The other two were ST13 and ST831, which have not been reported to have an XDR profile. All isolates carried multiple ARGs, dominated by those encoding β-lactamases (<i>bla</i> <sub>CTX-M-15</sub>: 93%, <i>bla</i> <sub>TEM</sub>: 70%), aminoglycoside-modifying enzymes (<i>aac(6')-Ib-cr5</i>: 77%, <i>aac(3)-IIe</i>: 64%), and efflux pump genes (<i>emrD</i>: 100%). The carbapenemase-encoding gene, <i>bla</i> <sub>NDM-5</sub>, was present in 13% of the isolates.</p><p><strong>Conclusions: </strong>This first genomic survey of <i>K. pneumoniae</i> in Zambia reveals extensive clonal diversity dominated by global high-risk lineages carrying plasmid-mediated ESBL and carbapenemase genes. The detection of XDR strains, particularly at UTH, underscores the urgent need to strengthen laboratory surveillance across all tertiary hospitals in Zambia and improve infection prevention programmes.</p>","PeriodicalId":73065,"journal":{"name":"Frontiers in antibiotics","volume":"5 ","pages":"1933211"},"PeriodicalIF":3.9,"publicationDate":"2026-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13690789/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149247818","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Environmental occurrence and dissemination of colistin resistance in contaminated aquatic systems: a systematic review of eight observational studies.","authors":"Alisha Sinha, Jogesh Murmu, Shreya Singh, Aditi Pal, Utkalika Mallick, Poonamrani Mishra, Krushna Chandra Sahoo, Mahesh Chandra Sahu, Sanghamitra Pati","doi":"10.3389/frabi.2026.1970443","DOIUrl":"10.3389/frabi.2026.1970443","url":null,"abstract":"<p><strong>Introduction: </strong>Colistin is a last-resort antibiotic used against multidrug-resistant Gram-negative bacterial infections. The emergence of plasmid-mediated colistin resistance, particularly mcr genes, has raised concerns about the environmental persistence and dissemination of resistance determinants. Aquatic environments may serve as reservoirs and dissemination pathways for colistin resistance; however, the available evidence remains fragmented. This systematic review aimed to synthesize evidence on the occurrence, resistance mechanisms, and environmental and potential public health implications of colistin resistance in contaminated aquatic systems.</p><p><strong>Methods: </strong>A systematic literature search was conducted in five electronic databases up to December 2024 in accordance with PRISMA guidelines. Studies investigating colistin resistance in wastewater, surface water, aquaculture systems, and related aquatic environmental matrices were eligible for inclusion. Following screening and eligibility assessment, eight observational studies were included. Owing to substantial methodological and outcome heterogeneity, a narrative synthesis was performed. Isolate-level phenotypic resistance, sample- or site-level molecular positivity, and metagenomic relative gene abundance were analyzed as separate, non-comparable outcome strata.</p><p><strong>Results: </strong>A total of 26,740 records were retrieved, of which 20,691 unique records were screened after removal of duplicates. Eight studies met the predefined eligibility criteria. The studies investigated diverse aquatic environments, including slaughterhouse effluents, municipal wastewater, urban rivers, aquaculture systems, and wastewater-associated bioaerosols. Plasmid-mediated mcr genes were identified across several environmental settings and frequently occurred alongside other antimicrobial resistance determinants. Chromosomal mechanisms of colistin resistance were also reported. The reported resistance measures varied substantially between studies, ranging from isolate-level phenotypic resistance and sample/site-level molecular detection to metagenomic relative abundance.</p><p><strong>Discussion: </strong>The available evidence indicates that contaminated aquatic environments can harbor colistin resistance determinants and may contribute to their environmental dissemination. However, the limited number of eligible studies and substantial methodological heterogeneity prevent direct quantitative comparison or estimation of a common environmental prevalence. Standardized surveillance approaches integrating culture-based methods, molecular detection, and genomic/metagenomic characterization are needed to improve comparability and clarify the environmental pathways of colistin resistance within a One Health framework.</p><p><strong>Systematic review registration: </strong>https://www.crd.york.ac.uk/PROSPERO/, identifier CRD42024613277.</p>","PeriodicalId":73065,"journal":{"name":"Frontiers in antibiotics","volume":"5 ","pages":"1970443"},"PeriodicalIF":3.9,"publicationDate":"2026-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13683747/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149240466","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Frontiers in antibioticsPub Date : 2026-10-01eCollection Date: 2026-01-01DOI: 10.3389/frabi.2026.1995353
Elmien Bronkhorst
{"title":"Editorial: Innovations and impacts of antimicrobial stewardship in primary care and proximity settings.","authors":"Elmien Bronkhorst","doi":"10.3389/frabi.2026.1995353","DOIUrl":"https://doi.org/10.3389/frabi.2026.1995353","url":null,"abstract":"","PeriodicalId":73065,"journal":{"name":"Frontiers in antibiotics","volume":"5 ","pages":"1995353"},"PeriodicalIF":3.9,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13670923/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149217384","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Frontiers in antibioticsPub Date : 2026-09-25eCollection Date: 2026-01-01DOI: 10.3389/frabi.2026.1905540
Lucas de Figueiredo Soveral, Liandra Raphaella de Lima Holanda, Izadora Borgmann Frizzo Assunção, Leticia Gonçalves Gomes, Isabella Bittencourt de Souza, Gabriella de Souza Rodrigues, Patrícia Almeida Vanny, Oscar Bruna-Romero, Jussara Kasuko Palmeiro, Mara Cristina Scheffer, Thais Cristine Marques Sincero, Carlos Rodrigo Zárate-Bladés
{"title":"Identification of antibiotic resistance genes in fecal microbiota selected donors during the establishment of a biobank in the south of Brazil.","authors":"Lucas de Figueiredo Soveral, Liandra Raphaella de Lima Holanda, Izadora Borgmann Frizzo Assunção, Leticia Gonçalves Gomes, Isabella Bittencourt de Souza, Gabriella de Souza Rodrigues, Patrícia Almeida Vanny, Oscar Bruna-Romero, Jussara Kasuko Palmeiro, Mara Cristina Scheffer, Thais Cristine Marques Sincero, Carlos Rodrigo Zárate-Bladés","doi":"10.3389/frabi.2026.1905540","DOIUrl":"https://doi.org/10.3389/frabi.2026.1905540","url":null,"abstract":"<p><p>Fecal microbiota transplantation (FMT) is an effective therapy for recurrent <i>Clostridioides difficile</i> infection (rCDI) and is increasingly explored for other dysbiosis-related disorders. However, its implementation as a regulated therapeutic strategy requires robust donor screening, biosafety frameworks, and standardized processing workflows. Here, we describe the establishment of the first fecal microbiota biobank in southern Brazil and evaluate the incorporation of metagenomic sequencing as a complementary layer of donor characterization and safety assessment. A structured donor selection pipeline based on international guidelines was implemented, integrating clinical screening, biochemical and serological testing, and microbiological analyses. Of 100 screened candidates, only four donors met all eligibility criteria and were included in the biobank, highlighting the stringency of the selection process. Shotgun metagenomic sequencing revealed a diverse resistome across all donors, including a shared core set of resistance genes alongside marked interindividual variability. Dominant resistance determinants included tetracycline-associated genes, <i>ermF</i>, CfxA-type β-lactamases, and aminoglycoside-modifying enzymes, which were associated with specific gut taxa. Genomic context analysis further identified four ARG-containing contigs with features compatible with potential mobility, although active horizontal gene transfer was beyond the scope of this study. Notably, <i>tet(Q)</i> and <i>ermF</i> were predominantly associated with <i>Bacteroides fragilis</i>, supporting its role as a reservoir of resistance determinants in the gut microbiota. These findings support the use of metagenomic profiling as a complementary approach to donor characterization and risk assessment rather than as a standalone criterion for donor exclusion. Overall, this study provides a framework for microbiota biobank implementation and highlights the potential of metagenomic analysis to complement conventional biosafety screening in FMT.</p>","PeriodicalId":73065,"journal":{"name":"Frontiers in antibiotics","volume":"5 ","pages":"1905540"},"PeriodicalIF":3.9,"publicationDate":"2026-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13649761/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149167193","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Prevalence and antimicrobial resistance profiles of <i>Campylobacter coli</i>, <i>Campylobacter jejuni</i>, and <i>Escherichia coli</i> in the poultry distribution network.","authors":"Sadik Dantroliya, Monica Chavan, Debashrita Mittra, Rameshchandra Pandit, Fiona Tomley, Damer Blake, Prakash Koringa, Chaitanya Joshi, Satyamitra Shekh, Chinmayi Joshi, Madhvi Joshi","doi":"10.3389/frabi.2026.1875259","DOIUrl":"10.3389/frabi.2026.1875259","url":null,"abstract":"<p><p>India is one of the largest producers of poultry and poultry-derived products. The dynamics of animal production and consumer exposure have been linked to new challenges in the control of poultry-borne zoonotic diseases as consumption of poultry products raises. As a part of the One Health Poultry Hub, this study focused on addressing the risk posed by pathogens associated to the intensification of poultry production. Eight cities in the state of Gujarat were included in the study based on poultry density and distribution networks (PDN). Samples were collected from 65 live bird market shops and 50 poultry farms. The prevalence of key food borne pathogens - specifically <i>Campylobacter</i> spp. and <i>Escherichia coli -</i> was assessed using cecal and cloacal samples from birds, while non-typhoidal <i>Salmonella</i> (NTS) spp. was examined in environment samples from poultry farms. <i>Campylobacter</i> spp. and <i>E. coli</i> were recovered from 10.26% and 51.33% birds, respectively, whereas NTS spp. was not detected in any environmental sample. Prevalence pattern varied by city, season and breed. The highest <i>C. coli</i> prevalence was in broiler shop samples from Surat (17.5%) and desi chickens form Bhuj (16.7%), while <i>C. jejuni</i> peaked in broiler shop samples from Bhuj (13.3%). <i>C. jejuni</i> was not detected in desi chickens. All isolates were further analyzed for antimicrobial susceptibility and resistance using the disc diffusion method. A higher resistance was observed in <i>Campylobacter</i> isolates (55.74%) particularly against fluoroquinolones, macrolides and beta-lactams. Among the isolated organisms, 39.34% of <i>Campylobacter</i> and 61.03% of <i>E. coli</i> isolates exhibited extensively drug-resistant (XDR) phenotypes, while 4.92% of <i>Campylobacter</i> and 9.09% of <i>E. coli</i> demonstrated pan drug-resistant (PDR) phenotypes. Among <i>Escherichia coli</i> isolates, 29.87% exhibited resistance to glycopeptides, nitrofurantoin, macrolides, tetracycline, beta-lactams, and fluoroquinolones. These findings underscore the critical need for implementing farm hygiene practices to mitigate the risk of food borne pathogens and antimicrobial resistance within poultry distribution networks.</p>","PeriodicalId":73065,"journal":{"name":"Frontiers in antibiotics","volume":"5 ","pages":"1875259"},"PeriodicalIF":3.9,"publicationDate":"2026-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13640147/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149119470","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Frontiers in antibioticsPub Date : 2026-09-18eCollection Date: 2026-01-01DOI: 10.3389/frabi.2026.1912287
Wael A Alghamdi, Khalid M Orayj, Ahmed R N Ibrahim, Marim A Abdelsalam, Abdullah M Alshehri
{"title":"Longitudinal trends in antimicrobial resistance phenotypes in <i>Pseudomonas aeruginosa</i>: a seven-year study.","authors":"Wael A Alghamdi, Khalid M Orayj, Ahmed R N Ibrahim, Marim A Abdelsalam, Abdullah M Alshehri","doi":"10.3389/frabi.2026.1912287","DOIUrl":"https://doi.org/10.3389/frabi.2026.1912287","url":null,"abstract":"<p><strong>Background: </strong><i>Pseudomonas aeruginosa</i> is a major cause of healthcare-associated infections and is increasingly associated with antimicrobial resistance. Continuous local surveillance is essential to monitor evolving resistance patterns and inform empirical antimicrobial therapy and antimicrobial stewardship.</p><p><strong>Methods: </strong>This retrospective laboratory-based surveillance study analyzed non-duplicate <i>P. aeruginosa</i> isolates recovered from hospitalized patients at a secondary healthcare setting in Saudi Arabia between 2018 and 2024. Resistance phenotypes were classified as multidrug-resistant (MDR), extensively drug-resistant (XDR), and difficult-to-treat resistance (DTR) according to established international definitions. Temporal trends were evaluated using logistic regression.</p><p><strong>Results: </strong>A total of 368 non-duplicate <i>P. aeruginosa</i> isolates were included. Respiratory tract specimens were the most common source of isolates. MDR prevalence increased from 51.0% in 2018 to a peak of 87.3% in 2022 before declining to 69.6% in 2024, while XDR reached its highest prevalence of 68.3% in 2023 before declining to 39.1% in 2024. When year was analyzed categorically, significant differences across years were observed for MDR (P < 0.001) and XDR (P = 0.003), but not DTR (P = 0.144).</p><p><strong>Conclusion: </strong>This seven-year surveillance study demonstrated a substantial burden of antimicrobial resistance among <i>P. aeruginosa</i> isolates, with significant year-to-year variation in MDR and XDR prevalence. These findings provide locally relevant surveillance data that may inform empirical antimicrobial therapy, antimicrobial stewardship, and ongoing institutional resistance surveillance.</p>","PeriodicalId":73065,"journal":{"name":"Frontiers in antibiotics","volume":"5 ","pages":"1912287"},"PeriodicalIF":3.9,"publicationDate":"2026-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13630743/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149119422","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Frontiers in antibioticsPub Date : 2026-09-15eCollection Date: 2026-01-01DOI: 10.3389/frabi.2026.1901158
Wasan Mohammed Abdulzahra, Zainab Qasim Hilo, Aswan Mahmood Hashim, Haider Nadhom Athab, Kawthar Abd Al-Hadi Abd Al-Karim, Hawraa Majid Hassan, Hussein Fadil Ibrahim, Ayad M J Al-Mamoori
{"title":"Isolation and identification of antibiotic-resistant bacteria in hospital tap water.","authors":"Wasan Mohammed Abdulzahra, Zainab Qasim Hilo, Aswan Mahmood Hashim, Haider Nadhom Athab, Kawthar Abd Al-Hadi Abd Al-Karim, Hawraa Majid Hassan, Hussein Fadil Ibrahim, Ayad M J Al-Mamoori","doi":"10.3389/frabi.2026.1901158","DOIUrl":"10.3389/frabi.2026.1901158","url":null,"abstract":"<p><strong>Introduction: </strong>Hospital tap water can act as a reservoir of opportunistic and potentially antibiotic-resistant bacteria, yet baseline data on the bacterial communities and antimicrobial resistance profiles of premise-plumbing systems remain scarce in Iraq. This study investigated the bacterial species present in hospital tap water and their antibiotic resistance profiles, with the aim of supporting infection control measures in healthcare settings.</p><p><strong>Methods: </strong>Tap water samples were collected from three hospitals in Babil Governorate, Iraq (Merjan Teaching Hospital, Turkish Hospital, and Al-Jiumhori Hospital) and were processed for heterotrophic plate counts and bacterial isolation. Isolates were identified to the species level using the VITEK 2 Compact automated phenotypic system, and antimicrobial susceptibility was determined on the same platform and interpreted according to Clinical and Laboratory Standards Institute guidelines.</p><p><strong>Results: </strong>A total of 11 bacterial isolates were recovered. The highest bacterial load was recorded in the Turkish Hospital sample (3.43 × 10<sup>4</sup> CFU/mL). The identified species comprised Granulicatella elegans, <i>Acinetobacter haemolyticus, Pseudomonas alcaligenes, Moraxella lacunata, Francisella tularensis, Aeromonas sobria, Pseudomonas stutzeri</i>, and <i>Sphingomonas paucimobilis</i>. The single Gram-positive isolate, G. elegans, showed the highest resistance (10 of 14 agents tested; 71.4%), whereas the Gram-negative isolates were largely susceptible, with only sporadic resistance detected in <i>P. stutzeri</i> and <i>M. lacunata</i>.</p><p><strong>Discussion: </strong>Because several species were represented by a single isolate and identification relied on an automated phenotypic platform, these resistance estimates are descriptive and should be interpreted with caution. The findings nonetheless confirm the presence of opportunistic and potentially resistant bacteria in hospital tap water and underscore the need for routine microbiological monitoring and improved water safety protocols.</p>","PeriodicalId":73065,"journal":{"name":"Frontiers in antibiotics","volume":"5 ","pages":"1901158"},"PeriodicalIF":3.9,"publicationDate":"2026-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13619893/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149083189","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}